Unilateral Axillary Lymphadenopathy Frequency and Follow-up Results After Inactivated COVID-19 Vaccination

Funda Dinç; Cenk Elibol; Murat Yunus Özdemir; Turhan Togan

Makale detayları

Unilateral Axillary Lymphadenopathy Frequency and Follow-up Results After Inactivated COVID-19 Vaccination

Yazarlar:

Funda Dinç | Cenk Elibol | Murat Yunus Özdemir | Turhan Togan

Yayıncı:

Mugla Sitki Kocman University

Ana Başlıklar:

Klinik Tıp Bilimleri (Diğer)

Dergi:

Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi Vol.11 Issue 3, pp.132-138

Belge Tipi:

Makale

Yayın Tarihi:

12/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001333836

pISSN:

2148-8118

Anahtar kelimeler:

Özet:

 Vaccine-induced ipsilateral axillary lymphadenopathy can be encountered with the widespread application of COVID-19 vaccines. The study aims to evaluate the frequency of axillary lymphadenopathy, sonographic features of axillary lymph nodes after administration of inactivated COVID-19 vaccine, and follow-up results. Between March and April 2021, a total of 127 participants were enrolled in this prospective study. Data were analyzed using both descriptive and exploratory test techniques with SPSS. A total of 127 participants 39.928.96 years, 68.5 men, who were between 10-16 days after the second dose vaccination, were evaluated for axillary lymph node status by initial ultrasound. A total of 32 participants 25.2 had ipsilateral axillary lymphadenopathy in the initial ultrasound. Only one of these patients had persistent lymphadenopathy on the control ultrasound 30 days later. The widest cortical thickness was significantly higher on the ipsilateral side 2.632.12 mm compared to the contralateral side 1.531.11 mm p.001. The number of lymphadenopathies was higher on the vaccinated side compared to the contralateral side p.001. A significant relationship between the history of COVID-19 infection and the absence of ipsilateral lymphadenopathy was found p.001. As a local adverse effect, ipsilateral axillary lymphadenopathy following the second dose of inactivated COVID-19 vaccine can be seen, and it usually regresses within a month. However, during that period, axillary lymphadenopathy is not expected in vaccinated individuals who previously experienced COVID-19 infection. Awareness and questioning of both infection and vaccination history before radiological examinations involving the axilla should help the radiologist avoid the misinterpretation of lymphadenopathy. It should be kept in mind that vaccine-induced ipsilateral axillary lymphadenopathy can be seen after inactivated COVID-19 vaccines in individuals who dont have a history of coronavirus infection, and it regresses a month later after detection.

 Vaccine-induced ipsilateral axillary lymphadenopathy can be encountered with the widespread application of COVID-19 vaccines. The study aims to evaluate the frequency of axillary lymphadenopathy, sonographic features of axillary lymph nodes after administration of inactivated COVID-19 vaccine, and follow-up results. Between March and April 2021, a total of 127 participants were enrolled in this prospective study. Data were analyzed using both descriptive and exploratory test techniques with SPSS. A total of 127 participants 39.928.96 years, 68.5 men, who were between 10-16 days after the second dose vaccination, were evaluated for axillary lymph node status by initial ultrasound. A total of 32 participants 25.2 had ipsilateral axillary lymphadenopathy in the initial ultrasound. Only one of these patients had persistent lymphadenopathy on the control ultrasound 30 days later. The widest cortical thickness was significantly higher on the ipsilateral side 2.632.12 mm compared to the contralateral side 1.531.11 mm p.001. The number of lymphadenopathies was higher on the vaccinated side compared to the contralateral side p.001. A significant relationship between the history of COVID-19 infection and the absence of ipsilateral lymphadenopathy was found p.001. As a local adverse effect, ipsilateral axillary lymphadenopathy following the second dose of inactivated COVID-19 vaccine can be seen, and it usually regresses within a month. However, during that period, axillary lymphadenopathy is not expected in vaccinated individuals who previously experienced COVID-19 infection. Awareness and questioning of both infection and vaccination history before radiological examinations involving the axilla should help the radiologist avoid the misinterpretation of lymphadenopathy. It should be kept in mind that vaccine-induced ipsilateral axillary lymphadenopathy can be seen after inactivated COVID-19 vaccines in individuals who dont have a history of coronavirus infection, and it regresses a month later after detection.

 Vaccine-induced ipsilateral axillary lymphadenopathy can be encountered with the widespread application of COVID-19 vaccines. The study aims to evaluate the frequency of axillary lymphadenopathy, sonographic features of axillary lymph nodes after administration of inactivated COVID-19 vaccine, and follow-up results. Between March and April 2021, a total of 127 participants were enrolled in this prospective study. Data were analyzed using both descriptive and exploratory test techniques with SPSS. A total of 127 participants 39.928.96 years, 68.5 men, who were between 10-16 days after the second dose vaccination, were evaluated for axillary lymph node status by initial ultrasound. A total of 32 participants 25.2 had ipsilateral axillary lymphadenopathy in the initial ultrasound. Only one of these patients had persistent lymphadenopathy on the control ultrasound 30 days later. The widest cortical thickness was significantly higher on the ipsilateral side 2.632.12 mm compared to the contralateral side 1.531.11 mm p.001. The number of lymphadenopathies was higher on the vaccinated side compared to the contralateral side p.001. A significant relationship between the history of COVID-19 infection and the absence of ipsilateral lymphadenopathy was found p.001. As a local adverse effect, ipsilateral axillary lymphadenopathy following the second dose of inactivated COVID-19 vaccine can be seen, and it usually regresses within a month. However, during that period, axillary lymphadenopathy is not expected in vaccinated individuals who previously experienced COVID-19 infection. Awareness and questioning of both infection and vaccination history before radiological examinations involving the axilla should help the radiologist avoid the misinterpretation of lymphadenopathy. It should be kept in mind that vaccine-induced ipsilateral axillary lymphadenopathy can be seen after inactivated COVID-19 vaccines in individuals who dont have a history of coronavirus infection, and it regresses a month later after detection.

 Aşılarının yaygınlaşmasıyla birlikte aşıya bağlı ipsilateral aksiller lenfadenopati ile karşılaşılabilmektedir. Çalışmanın amacı inaktive COVİD-19 aşısı sonrası aksiller lenfadenopati sıklığını, lenf bezlerinin sonografik özelliklerini ve takip sonuçlarını değerlendirmektir. Mart-Nisan 2021 tarihleri arasında gerçekleştirilen prospektif çalışmaya toplam 127 katılımcı dahil edilmiştir. Tanımlayıcı ve çıkarımsal istatistiksel analizler SPSS kullanılarak gerçekleştirilmiştir. İkinci doz aşılamadan sonra 10-16 günlük süreçte 127 katılımcının 39.928.96 yaşında, 68.5i erkek ultrasonografi ile aksiller lenf nodu durumu değerlendirildi. Toplam 32 katılımcıda 25.2 ilk ultrasonda ipsilateral aksiller lenfadenopati görüldü. Bu hastalardan yalnızca birinde 30 gün sonraki kontrol ultrasonda sebat eden lenfadenopati görüldü. Lenf nodu korteks kalınlığı en kalın yerinde aşılanan tarafta 2.632.12 mm karşı tarafa 1.531.11 mm göre anlamlı derecede yüksekti p.001. Lenfadenopati sayısı aşılanan tarafta karşı tarafa göre daha yüksekti p.001. Ayrıca COVİD-19 öyküsü ile ipsilateral lenfadenopati bulunmaması arasında anlamlı ilişki mevcuttu p.001. Lokal bir yan etki olarak inaktive COVİD-19 aşısının ikinci dozu sonrasında ipsilateral aksiller lenfadenopati görülebilmekte ve genellikle 1 ay içinde gerilemektedir. Ancak daha önce COVİD-19 enfeksiyonu geçiren bireylerde aşı sonrası aksiller lenfadenopati beklenmemektedir. Aksillayı ilgilendiren radyolojik incelemelerden önce hem enfeksiyon hem de aşılama geçmişinin bilinmesi, radyoloğun lenf nodu durumunu yanlış yorumlanmasını engelleyecektir. Aşıya bağlı ipsilateral aksiller lenfadenopatinin, koronavirus enfeksiyon öyküsü olmayan bireylerde inaktif COVİD-19 aşıları sonrasında görülebileceği ve tespit edildikten bir ay sonra çoğunlukla kaybolduğu akılda tutulmalıdır.

Makale detayları

Unilateral Axillary Lymphadenopathy Frequency and Follow-up Results After Inactivated COVID-19 Vaccination

Yazarlar:

Funda Dinç | Cenk Elibol | Murat Yunus Özdemir | Turhan Togan

Yayıncı:

Mugla Sitki Kocman University

Ana Başlıklar:

Klinik Tıp Bilimleri (Diğer)

Dergi:

Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi Vol.11 Issue 3, pp.132-138

Belge Tipi:

Makale

Yayın Tarihi:

12/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001333836

pISSN:

2148-8118

Vaccination

Covid-19

Cortical Thickness

Lymphadenopathy

UltrasoundAşılama

Covid-19

Kortikal Kalınlık

Lenfadenopati

Ultrasonografi

Sayı

Makale detayları

Yazarlar: Funda Dinç | Cenk Elibol | Murat Yunus Özdemir | Turhan Togan

Yayıncı: Mugla Sitki Kocman University

Ana Başlıklar: Klinik Tıp Bilimleri (Diğer)

Dergi: Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi Vol.11 Issue 3, pp.132-138

Belge Tipi: Makale

Yayın Tarihi: 12/2024

Belge Dili: İngilizce

Document ID (Org No.): 2001333836

pISSN: 2148-8118

Sayı

Yazarlar:

Funda Dinç | Cenk Elibol | Murat Yunus Özdemir | Turhan Togan

Yayıncı:

Mugla Sitki Kocman University

Ana Başlıklar:

Klinik Tıp Bilimleri (Diğer)

Dergi:

Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi Vol.11 Issue 3, pp.132-138

Belge Tipi:

Makale

Yayın Tarihi:

12/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001333836

pISSN:

2148-8118